NYBOMYCIN, A NEW ANTIBIOTIC WITH ANTIPHAGE AND ANTIBACTERIAL PROPERTIES.

@article{Strelitz1955NYBOMYCINAN,
  title={NYBOMYCIN, A NEW ANTIBIOTIC WITH ANTIPHAGE AND ANTIBACTERIAL PROPERTIES.},
  author={Frida Strelitz and H Flon and I N Asheshov},
  journal={Proceedings of the National Academy of Sciences of the United States of America},
  year={1955},
  volume={41 9},
  pages={
          620-4
        }
}
  • F. Strelitz, H. Flon, I. Asheshov
  • Published 15 September 1955
  • Biology
  • Proceedings of the National Academy of Sciences of the United States of America
l R. W. Shideler, Ph.D. thesis, University of Texas, Austin, 1955; W. D. Brown, Ph.D. thesis, University of Texas, Austin, 1955. 2 M. K. Young, H. K. Berry, E. Beerstecher, Jr., and J. S. Berry, University of Texas Publication No. 5109 ("Biochemial Institute Studies," Vol. 4 [Austin: University of Texas, 19511), p .189. 3L. Bellak, Dementia Praecox (New York: Grune & Stratton, 1948), p. 27. 4R. J. Williams, E. Beerstecher, Jr., and L. J. Berry, Lancet, p. 287, February 18, 1950. 5 R.; J… 

Figures and Tables from this paper

AKLAVIN, AN ANTIBIOTIC SUBSTANCE WITH ANTIPHAGE ACTIVITY

TLDR
Investigations with culture A 1165 resulted in the isolation of orange-colored crystalline salts (hydrochloride, picrate, helianthate) of a nitrogen-containing base which itself was not obtained crystalline, and these salts were probably not homogeneous.

Apigenin as an anti-quinolone-resistance antibiotic.

Deoxynybomycins inhibit mutant DNA gyrase and rescue mice infected with fluoroquinolone-resistant bacteria

TLDR
Using a DNM derivative, the first in-vivo efficacy of the nybomycin class is demonstrated in a mouse infection model and the data presented suggest the promise of DNM derivatives for the treatment of FQR infections.

Future Chemotherapy Preventing Emergence of Multi-Antibiotic Resistance

TLDR
The extreme flexibility of this organism to survive antibiotic pressure is identified and antibiotics with such unique properties reverse antibiotics (RA) are designated by using RA and extant antibiotics in a well-controlled way to establish sophisticated anti-microbial chemotherapy in the future.

Multi-drug-resistant Staphylococcus aureus and future chemotherapy.

  • K. HiramatsuY. Katayama T. Baba
  • Biology, Medicine
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
  • 2014

Synthetic studies on the reverse antibiotic natural products, the nybomycins.

TLDR
A new scalable and robust synthetic route to the nybomycin natural products is reported to aid in the development of this series of antibiotics, confirming the selectivity for fluoroquinolone resistant bacteria and potential future opportunities for further optimisation.

Heterologous Expression of the Nybomycin Gene Cluster from the Marine Strain Streptomyces albus subsp. chlorinus NRRL B-24108

TLDR
The identification of the previously uncharacterized nybomycin gene cluster from the marine actinomycete Streptomyces albus subsp.